An endogenous peptide that causes vasodilation and is inactivated by angiotensin converting enzyme is:
**Core Concept:** Endogenous peptides play a crucial role in regulating the cardiovascular system, and angiotensin converting enzyme (ACE) is a key enzyme involved in their processing. ACE is responsible for converting angiotensin I to angiotensin II, a potent vasoconstrictor. In contrast, some endogenous peptides, when activated, cause vasodilation.
**Why the Correct Answer is Right:** The correct answer is D, bradykinin. Bradykinin is an endogenous peptide that belongs to the kinin family and functions as a vasodilator. In contrast to angiotensin II, which is a potent vasoconstrictor, bradykinin promotes dilation of blood vessels.
**Why Each Wrong Option is Incorrect:**
A. **Angiotensin II:** This is a potent vasoconstrictor, not a vasodilator. Angiotensin II is formed from angiotensin I through the action of ACE, which is why it is not the correct answer.
B. **Endothelin:** Endothelin is another vasoconstrictor peptide, not a vasodilator. It is produced by endothelial cells and is involved in the regulation of blood pressure.
C. **Nitric oxide (NO):** Nitric oxide is a vasodilator, released by endothelial cells, and plays a significant role in maintaining vascular tone and blood pressure regulation.
**Clinical Pearl:** Understanding the role of different peptides in the regulation of blood pressure is crucial for clinicians as it helps in diagnosing and treating various cardiovascular disorders. ACE inhibitors and angiotensin II receptor blockers (ARBs) are commonly used in the management of hypertension and heart failure, targeting the renin-angiotensin-aldosterone system (RAAS). By inhibiting the RAAS, these medications help lower blood pressure and improve cardiac function.